Abstracts and Posters
 |
Multiplex Development of 35 New Cancer-Related Immunoassays View Poster |
|
|
|
|
Challenges in Development and Validation of a Multiplex Assay to Detect Biomarkers in Human Serum and Cerebrospinal Fluid View Poster |
|
|
|
|
Reduced responsiveness of circulating leukocytes following metal-rich particulate matter exposure View Abstract |
|
|
|
|
Development of a Multiplex Immunoassay biomarker panel for Spinal Muscular Atrophy View Poster |
|
|
|
|
The OncologyMAP® service delivers data from the quantitative measurement of 101 cancer-related serum proteins. This novel service offering is an unprecedented tool for broad applications in oncology. View Poster |
|
|
|
|
Rules-Based Medicine – Innovative Biomarker Solutions View Poster |
|
|
|
|
Novel Biomarkers of Cisplatin-induced Kidney Damage View Poster |
|
|
|
|
The Clinical Phenotype of Myelofibrosis Encompasses a Chronic Inflammatory State that is Favorably Altered by INCB018424, a Selective Inhibitor of JAK1/2 View Poster | View Abstract |
|
|
|
|
Development and Validation of a Multi-Analyte Profile (MAP) of Putative Biomarkers of Human Kidney Damage View Poster | View Abstract |
|
|
|
|
Development of a new 3D-Human Airway Epithelium/ Whole-blood Co-culture Model Combined with Multi-AnalyteProfile (MAP) Analyses for Assessing Drug Effects View Poster |
|
|
|
|
EDI-Co gut, a human co-culture from intestinal epithelia and whole-blood used as test model to characterize the effects of microbial metabolites on immune-cell function View Poster |
|
|
|
|
EDI-Co Skin 3D-Co-culture model combined with RBM MAP analyses: Optimized examination of human immune cell function in skin product testing View Poster |